Sterling Capital Management LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1329883
CHARLOTTE, NC
Position in AMRX
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$281,228
-$163,501 QoQ
Shares Held
22,625
-35.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 93.42762430939227.ToString("F0")%
Shared 0.ToString("F0")%
None 6.572375690607735.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sterling Capital Management LLC holds $21,914,421 across 40 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
450,992 | $13,583,878 | |
| 2 | VTRS |
Viatris Inc
|
232,342 | $3,138,940 | |
| 3 | ZTS |
Zoetis Inc.
|
8,983 | $1,061,880 | |
| 4 | HLN |
Haleon plc
|
94,183 | $942,771 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,429 | $847,368 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
16,596 | $397,142 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
22,625 | $281,228 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
11,270 | $254,702 |
All Filings in AMRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $281,228 | 22,625 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $444,729 | 35,296 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $349,949 | 34,960 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,698 | 828 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,852 | 579 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,595 | 959 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,813 | 218 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||